HPV Related Disease Burden and Impact of HPV Vaccine


At the conclusion of the presentation, the participants will be able to:

  1. Discuss the burden of clinical disease related to infection with the Human Papilloma Virus (HPV);
  2. Restate the recommendations from the Advisory Committee on Immunization Practices (ACIP) on HPV vaccination for pre-teens;
  3. Describe the safety and efficacy of the HPV vaccine; and
  4. Explain the challenges limiting optimal uptake of the HPV vaccine.

* Fields marked with an asterisk are required

Participant Information

Are you Hispanic, Latino/a, or Spanish origin? * (One or more categories may be selected)
What is your race? * (One or more categories may be selected)

Motivation to Participate

Program Evaluation

Using the rating scale, please rate the following.

Learning Outcome

Objectives/Learner's achievement of each objective
As a result of this educational activity, I am able to:


Presenter 1
Martin Mahoney, MD, PhD, Roswell Park Cancer Institute

Conflict of Interest

Outcomes of Education

Please list up to three specific barriers you have identified that will prevent you from incorporating what you have learned into practice.


Please list up to three specific strengths of this learning activity/offering.

Please list up to three specific areas to improve this learning activity/offering.

Submit Evaluation

(Not eligible for continuing education credits)